Skip to main content
Karthik Suresh, MD, Pulmonology, Baltimore, MD, Johns Hopkins Hospital

KarthikSureshMD

Pulmonology Baltimore, MD

Critical Care Medicine, Pleural Disease

Associate Professor of Medicine

Dr. Suresh is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Suresh's full profile

Already have an account?

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Pulmonary Disease and Critical Care Medicine, 2011 - 2016
  • Johns Hopkins University
    Johns Hopkins UniversityChief Residency, Internal Medicine, 2012 - 2013
  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Internal Medicine, 2008 - 2011
  • University of Louisville School of Medicine
    University of Louisville School of MedicineClass of 2008
  • University of Louisville
    University of LouisvilleBS, Mathematics , 2000 - 2004

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 2012 - 2025
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Critical Care Medicine
  • American Board of Internal Medicine Pulmonary Disease

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Immune-Related (IR)-Pneumonitis During the COVID-19 Pandemic: Multidisciplinary Recommendations for Diagnosis and Management  
    Joshua E Reuss, Karthik Suresh, David Feller-Kopman, Clare Rock, Julie R Brahmer, Journal For Immunotherapy of Cancer
  • Impact of Checkpoint Inhibitor Pneumonitis on Survival in Non-Small Cell Lung Cancer Patients Receiving Immune Checkpoint Immunotherapy  
    Karthik Suresh, David Feller-Kopman, Lonny Yarmus, Sonye K Danoff, Journal of Thoracic Oncology
  • Pneumonitis in Non-Small Cell Lung Cancer Patients Receiving Immune Checkpoint Immunotherapy: Incidence and Risk Factors  
    Karthik Suresh, David Feller-Kopman, Lonny Yarmus, Sonye K Danoff, Journal of Thoracic Oncology

Press Mentions

  • Researchers Characterize Lung Inflammation Associated with Some Cancer Immnunotherapy
    Researchers Characterize Lung Inflammation Associated with Some Cancer ImmnunotherapySeptember 5th, 2019
  • Pharmacovigilance Needed for Immune Checkpoint Inhibitor Therapy in NSCLC
    Pharmacovigilance Needed for Immune Checkpoint Inhibitor Therapy in NSCLCAugust 29th, 2019

Hospital Affiliations